| Trial name or title | Efficacy and safety of smoking cessation with varenicline tartrate in diabetic smokers (DIASMOKE) |
| Methods | Randomised double‐blind placebo‐controlled trial |
| Participants | 300 adult smokers with type 2 diabetes |
| Interventions | Varenicline 1 mg x 2/day for 12 weeks vs placebo |
| Outcomes | CAR at week 24; safety; CAR at week 52; adverse events |
| Starting date | June 2011 |
| Contact information | Riccardo Polosa |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.